Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation-Reference-Cited by-同舟云学术

Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation

Author:

Biroschak Julianne R.¹,Schwartz Gordon F.²,Palazzo Juan P.³,Toll Adam D.⁴,Brill Kristin L.⁵,Jaslow Rebecca J.⁶,Lee Sun Yong⁷

Affiliation:

1. Department of Obstetrics and Gynecology; The George Washington University Hospital; Washington; District of Columbia

2. Department of Surgery; Thomas Jefferson University Hospital; Philadelphia; Pennsylvania

3. Department of Pathology; Anatomy, and Cell Biology; Thomas Jefferson University Hospital; Philadelphia; Pennsylvania

4. Department of Pathology, Johns Hopkins; Baltimore; MD

5. Department of Surgery; Cooper University Hospital; Voorhees; New Jersey

6. Department of Medical Oncology; Thomas Jefferson University Hospital; Philadelphia; Pennsylvania

7. Department of Surgery; Aria Health System; Philadelphia; Pennsylvania

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

Reference27 articles.

1. Cancer Statistics, 2010;Jemal;CA Cancer J Clin,2010

4. Breast cancer research and treatment;NCI Alert on Node-negative breast cancer;Breast Cancer Res Treat,1988

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Biomarkers in Cancer Survival and Drug Resistance;Cancer Biomarkers in Diagnosis and Therapeutics;2022